298 related articles for article (PubMed ID: 29494739)
1. Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.
Joshi SS; Handorf E; Strauss D; Correa AF; Kutikov A; Chen DYT; Viterbo R; Greenberg RE; Uzzo RG; Smaldone MC; Geynisman DM
JAMA Oncol; 2018 May; 4(5):643-649. PubMed ID: 29494739
[TBL] [Abstract][Full Text] [Related]
2. More lymph node dissection improves survival in patients with newly diagnosed lymph node-positive penile cancer.
Mao W; Huang X; Kong M; Fan J; Geng J
Int Urol Nephrol; 2019 Apr; 51(4):641-654. PubMed ID: 30758771
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study.
Sharma P; Djajadiningrat R; Zargar-Shoshtari K; Catanzaro M; Zhu Y; Nicolai N; Horenblas S; Spiess PE
Urol Oncol; 2015 Nov; 33(11):496.e17-23. PubMed ID: 26072110
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma.
Radadia KD; Rivera-Núñez Z; Kim S; Farber NJ; Sterling J; Falkiewicz M; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
Urol Oncol; 2019 Sep; 37(9):577.e17-577.e25. PubMed ID: 31280982
[TBL] [Abstract][Full Text] [Related]
5. Disparity between pre-existing management of penile cancer and NCCN guidelines.
Campbell RA; Slopnick EA; Ferry EK; Zhu H; Kim SP; Abouassaly R
Urol Oncol; 2017 Aug; 35(8):531.e9-531.e14. PubMed ID: 28363474
[TBL] [Abstract][Full Text] [Related]
6. Disease-specific survival after radical lymphadenectomy for penile cancer: prediction by lymph node count and density.
Li ZS; Yao K; Chen P; Zou ZJ; Qin ZK; Liu ZW; Li YH; Zhou FJ; Han H
Urol Oncol; 2014 Aug; 32(6):893-900. PubMed ID: 24994488
[TBL] [Abstract][Full Text] [Related]
7. Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database.
Winters BR; Kearns JT; Holt SK; Mossanen M; Lin DW; Wright JL
Urol Oncol; 2018 Mar; 36(3):92.e11-92.e16. PubMed ID: 29174944
[TBL] [Abstract][Full Text] [Related]
8. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
[TBL] [Abstract][Full Text] [Related]
9. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database.
Correa AF; Handorf E; Joshi SS; Geynisman DM; Kutikov A; Chen DY; Uzzo RG; Viterbo R; Greenberg RE; Smaldone MC
J Urol; 2018 May; 199(5):1238-1244. PubMed ID: 29248557
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma.
Reddy JP; Pettaway CA; Levy LB; Pagliaro LC; Tamboli P; Rao P; Jayaratna I; Hoffman KE
BJU Int; 2017 Apr; 119(4):591-597. PubMed ID: 27753187
[TBL] [Abstract][Full Text] [Related]
11. Lymph node density predicts recurrence and death after inguinal lymph node dissection for penile cancer.
Ball MW; Schwen ZR; Ko JS; Meyer A; Netto GJ; Burnett AL; Bivalacqua TJ
Investig Clin Urol; 2017 Jan; 58(1):20-26. PubMed ID: 28097264
[TBL] [Abstract][Full Text] [Related]
12. A 10-year retrospective audit of penile cancer management in the UK.
Mistry T; Jones RW; Dannatt E; Prasad KK; Stockdale AD
BJU Int; 2007 Dec; 100(6):1277-81. PubMed ID: 17850372
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis.
Xu J; Li G; Zhu SM; Cai QL; Wang Z; Yang X; Zhang HT; Niu YJ
BMC Cancer; 2019 Jun; 19(1):625. PubMed ID: 31238987
[TBL] [Abstract][Full Text] [Related]
14. Management of Lymph Node-positive Penile Cancer: A Systematic Review.
Sachdeva A; McGuinness L; Zapala Ł; Greco I; Garcia-Perdomo HA; Kailavasan M; Antunes-Lopes T; Ayres B; Barreto L; Campi R; Crook J; Johnstone P; Kumar V; Manzie K; Marcus JD; Necchi A; Oliveira P; Osborne J; Pagliaro LC; Protzel C; Bryan Rumble R; Sánchez Martínez DF; Spiess PE; Tagawa ST; van der Heijden MS; Parnham AS; Pettaway CA; Albersen M; Sangar VK; Brouwer OR; Sakalis VI
Eur Urol; 2024 Mar; 85(3):257-273. PubMed ID: 37208237
[TBL] [Abstract][Full Text] [Related]
15. Contemporary management of regional nodes in penile cancer-improvement of survival?
Djajadiningrat RS; Graafland NM; van Werkhoven E; Meinhardt W; Bex A; van der Poel HG; van Boven HH; Valdés Olmos RA; Horenblas S
J Urol; 2014 Jan; 191(1):68-73. PubMed ID: 23917166
[TBL] [Abstract][Full Text] [Related]
16. Inguinal lymph node density as a powerful predictor of cancer specific survival in patients with node-positive penile cancer.
Chavarriaga J; Camacho D; Suso-Palau D; Godoy F; Cabrera M; Forero J; López-de-Mesa B; Varela R
Urol Oncol; 2021 Dec; 39(12):839.e1-839.e8. PubMed ID: 34400069
[TBL] [Abstract][Full Text] [Related]
17. Population-based assessment of the number of lymph nodes removed in the treatment of penile squamous cell carcinoma.
Zhu Y; Gu CY; Ye DW
Urol Int; 2014; 92(2):186-93. PubMed ID: 24246932
[TBL] [Abstract][Full Text] [Related]
18. Lymph node yield as a predictor of overall survival following inguinal lymphadenectomy for penile cancer.
Soodana-Prakash N; Koru-Sengul T; Miao F; Lopategui DM; Savio LF; Moore KJ; Johnson TA; Alameddine M; Barboza MP; Parekh DJ; Punnen S; Gonzalgo ML; Ritch CR
Urol Oncol; 2018 Oct; 36(10):471.e19-471.e27. PubMed ID: 30143385
[TBL] [Abstract][Full Text] [Related]
19. Log ODDS (LODDS) of positive lymph nodes as a predictor of overall survival in squamous cell carcinoma of the penis.
Patel KN; Salunke A; Bhatt S; Sharma M; Jain A; Puj K; Rathod P; Warikoo V; Pandya SJ
J Surg Oncol; 2021 May; 123(8):1836-1844. PubMed ID: 33684233
[TBL] [Abstract][Full Text] [Related]
20. Usage and survival implications of surgical staging of inguinal lymph nodes in intermediate- to high-risk, clinical localized penile cancer: A propensity-score matched analysis.
Woldu SL; Ci B; Hutchinson RC; Krabbe LM; Singla N; Passoni NM; Clinton TN; Raj GV; Miller DS; Sagalowsky AI; Lotan Y; Xie Y; Margulis V; Bagrodia A
Urol Oncol; 2018 Apr; 36(4):159.e7-159.e17. PubMed ID: 29288008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
